Allied Biotech Corporation (TPEX:1780)

Allied Biotech Revenue

Allied Biotech had revenue of 210.17M TWD in the quarter ending September 30, 2025, with 9.00% growth. This brings the company's revenue in the last twelve months to 821.81M, up 3.86% year-over-year. In the year 2024, Allied Biotech had annual revenue of 806.92M with 12.00% growth.

• Revenue (ttm): 821.81M
• Revenue Growth: +3.86%
• P/S Ratio: 2.86
• Revenue / Employee: 20.55M
• Employees: 40
• Market Cap: 2.35B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	806.92M	86.49M	12.00%
Dec 31, 2023	720.43M	3.69M	0.51%
Dec 31, 2022	716.75M	39.99M	5.91%
Dec 31, 2021	676.76M	58.69M	9.50%
Dec 31, 2020	618.07M	-21.33M	-3.34%